Assessment of the quality of life of patients who have had COVID-19 infection, in mild and moderate forms
https://doi.org/10.58708/2074-2088.2023-1(29)-75-81
Abstract
The COVID-19 infection pandemic is characterized by high morbidity, unclear prognosis of complications and a decrease in the quality of life of patients. The article presents the results of a prospective single-center cohort study of the quality of life of 134 patients who suffered from COVID-19 infection in mild and moderate forms. 99 patients reported the presence of any disorders at the time of the survey, 35 patients reported the absence of problems. 53,7% of respondents were concerned about moderate pain and/or discomfort, 41,8% of patients experienced a feeling of anxiety and/or depression and moderate mobility disorders. The median for EQ-VAS in patients with no symptoms was significantly higher compared to the median for EQ-VAS in patients with any problems (80 points versus 65 points, respectively). After a COVID-19 infection, mild to moderate forms of pain and/or discomfort, anxiety and/or depression, impaired mobility are present in half of the subjects, which leads to a decrease in the quality of life of patients.
About the Authors
O. L. NikiforovaBelarus
N. V. Galinovskaya
Belarus
E. V. Voropaev
Belarus
References
1. World Health Organization. Coronavirus diseace (COVID-19) pandemic, 2022. [Electronic resource]. Global website of the world health organization. [date of access 2022 October 10]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus- 2019
2. JHU: Онлайн статистика по пациентам с COVID-19 Университета Johns Hopkins University. Режим доступа : https://coronavirus.jhu.edu/map.html Дата доступа - 10.10.2022.
3. Антонович, Ж.В. Длительный COVID и постковидный синдром как междисциплинарная проблема / Ж.В. Антонович // Рецепт. – 2022. – Т. 25(4). – С. 5-42. DOI: https://doi.org/10.34883/ PI2022.25.4.010
4. Post-COVID-19 syndrome / D. Montani [et al.] // Eur Respir Rev. 2022; 31(163):210185. DOI: 10.1183/16000617.0185-2021
5. Post-COVID-19 Syndrome / J.D. Pierce [et al.] // Nurs Res. – 2022. – Vol. 71(2). – P. 164-174. DOI: 10.1097/NNR.0000000000000565
6. Популяционные показатели качества жизни, связанного со здоровьем по опроснику EQ-5D / Е.А. Александрова [и др.] // Здравоохра- нение Российской Федерации. – 2018. – Т. 62(6). – С. 295-303. DOI: http://dx.doi.org/10.18821/0044- 197Х-2018-62-6-295-303
7. Mohammed, M.A. Pharmaceutical care and health related quality of life outcomes over the past 25 years: Have we measured dimensions that really matter? / M.A. Mohammed, R.J. Moles, T.F. Chen // Int J Clin Pharm. – 2018. – Vol. 40(1). – P. 3-14. DOI: 10.1007/s11096-017-0582-8
8. Новик, А.А. Руководство по исследова- нию качества жизни в медицине. 2-е издание / А.А. Новик, Т.И. Ионова, Под ред. Акад. РАМН Ю.Л. Шевченко. – М.: ЗАО «ОЛМА Медиа Групп», 2007. – 320 с. DOI: https://www.cpkmed.ru/materials/ El_Biblio/AktualDoc/osnovy-zdravoohranenija/5.pdf
9. A comparative review of generic qualityof- life instruments / S.J. Coons [et al.] // Pharmacoeconomics. – 2000. – Vol. 17(1). – P. 13-35. DOI: 10.2165/00019053-200017010-00002
10. Valuation of the EQ-5D-3L in Russia / V. Omelyanovskiy [et al.] // Qual Life Res. – 2021. – Vol. 30(7). – P. 1997-2007. DOI: 10.1007/s11136-021- 02804-6
11. Devlin, N.J. EQ-5D and the EuroQol Group: Past, Present and Future. / N.J. Devlin, R. Brooks // Appl Health Econ Health Policy. – 2017. – Vol. 15(2). – P. 127-137. DOI: 10.1007/s40258-017-0310-5
12. Post-Intensive Care Unit Syndrome in a Cohort of COVID-19 Survivors in New York City. / K. Weidman [et al.] // Ann Am Thorac Soc. – 2022. – Vol. 19(7). – P. 1158-1168. DOI: 10.1513/ AnnalsATS.202104-520OC
13. Post-Intensive Care Syndrome in Survivors from Critical Illness including COVID-19 Patients: A Narrative Review / C.S. Vrettou [et al.] // Life (Basel). – 2022. – Vol. 12(1). – P. 107. DOI: 10.3390/life12010107
14. Evaluation of health-related quality of life of Covid-19 patients: a hospital-based study in South Central Ethiopia / A.W. Kaso [et al.] // Health Qual Life Outcomes. – 2021. – Vol. 19(1). – P. 268. DOI: 10.1186/s12955-021-01900-y
15. Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients / S. Tsuzuki [et al.] // Health Qual Life Outcomes. – 2022. – Vol. 20(1). – P. 125. DOI: 10.1186/s12955-022-02033-6
16. Health-Related Quality of Life and Its Socio- Demographic and Behavioural Correlates during the COVID-19 Pandemic in Estonia / M. Tamson [et al.] // Int J Environ Res Public Health. – 2022. – Vol. 19(15). – P. 9060. DOI: 10.3390/ijerph19159060
17. The impact of Post-COVID-Syndrome on functioning - results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany / C. Lemhöfer [et al.] // J Occup Med Toxicol. – 2021. – Vol. 16(1). – P. 45. DOI: 10.1186/s12995- 021-00337-9
18. Андреев, Д.А. Базовые варианты анкеты EQ-5D – стандартные международные инструмен- ты оценки качества жизни. Краткий обзор литера- туры / Д.А. Андреев, А.А. Завьялов, А.Ю. Кашур- ников // Здоровье мегаполиса. – 2021. – Vol. 2(1). – P. 62-69. DOI: https://doi.org/10.47619/2713-2617. zm.2021.v2i1;62-69
19. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary / F. Rencz [et al.] // Value Health. – 2020. – Vol. 23(9). – P. 1235- 1245. DOI: 10.1016/j.jval.2020.03.019
20. Амирджанова, В.Н. Валидация русской версии общего опросника EuroQol-5D (EQ-5D) / В.Н. Амирджанова, Ш.Ф. Эрдес // Научно-практи- ческая ревматология. – 2007. – Т. 45(3). – С. 69-76. DOI: https://doi.org/10.14412/1995-4484-2007-691
Review
For citations:
Nikiforova O.L., Galinovskaya N.V., Voropaev E.V. Assessment of the quality of life of patients who have had COVID-19 infection, in mild and moderate forms. Medical and Biological Problems of Life Activity. 2023;(1):75-81. (In Russ.) https://doi.org/10.58708/2074-2088.2023-1(29)-75-81